What is it about?
A rare tree of the Greek mountains, the European yew (Taxus baccata), may contribute to the development of anticancer therapeutics. A research team coordinated by Professor F.A. (Phil) Aravanopoulos of the Laboratory of Forest Genetics at the Aristotle University of Thessaloniki (AUTH) identified important populations of the species in Greece as valuable natural sources of compounds employed in clinically established anticancer treatments. Taxanes—natural chemical compounds produced by yew trees—are key components of drugs such as paclitaxel (Taxol), used to treat various forms of cancer. The study examined three peripheral populations of yew in northern Greece, in the mountains of Cholomon, Olympus, and Vourinos, assessing their genetic diversity, chemical diversity, and epigenetic characteristics. This is the first time Greek yew populations have been studied using such an integrated approach. The results revealed significant differences among populations in the production of anticancer taxanes, as well as notable seasonal variation in their concentrations. The compound 10-deacetylbaccatin III, an important precursor for the semi-synthetic production of paclitaxel, was identified as the most abundant taxane, with the highest levels observed in the Mt. Olympus population. The analyses also demonstrated high genetic diversity and clear differentiation among populations, along with notable levels of DNA methylation, indicating adaptive potential under changing environmental conditions
Featured Image
Photo by Yana Gorbunova on Unsplash
Why is it important?
The findings highlight the potential for developing genetic improvement programs based on the identification and clonal propagation of high taxane-producing trees, while maintaining the genetic diversity of natural populations. This creates new opportunities for the sustainable production of medically valuable compounds. At the same time, the study underscores the urgent need to protect the remaining yew populations in Greece, which are rare and fragmented, often consisting of fewer than 50 individuals. The researchers propose expanding protected areas that include the small yew forests, establishing gene conservation units (GCUs), monitoring genetic diversity, banning logging, regulating grazing, and developing ex situ conservation programs using material from multiple populations. The research was funded through the Greek National Strategic Reference Framework (NSRF), and its full results have been recently published in PLOS ONE, a leading international peer-reviewed open-access journal.
Perspectives
What makes this study stand out, at least to me, is how (starting from an almost intuitive conceptual basis), led to the connection of fields that don’t always “talk” to each other—forest genetics, ecology and medical applications. Beyond being just another paper describing variation in plant populations, it actually shows clearly an example of how something growing quietly in the mountains can matter for something as big as cancer treatment. One of the strongest aspects is the multifaceted approach by looking at several layers of the research problem at once: genetic, epigenetic, and chemical variation. That kind of combined view isn’t very common, especially in forest tree research, and it really helps you see a comprehensive picture. What’s particularly interesting is how much variation has been found, not just between different locations, but across seasons too. These trees aren’t producing the same compounds all the time. Their chemistry shifts depending on when and where you look; a manifestation of a living system’s response to spatial and temporal environmental variation and change. Another thing is the focus on Greek populations close to the edge of the species’ range. Normally, you might expect these marginal populations to be less important. But here, they turn out to be quite the opposite - genetically diverse and clearly distinct. It’s a reminder that what looks peripheral on a map can actually be central in terms of biological value. More broadly, the study gently reframes how we think about conservation. It’s not only about protecting nature for its own sake, important as that is, but also about safeguarding potential resources we don’t fully understand yet. In this case, a relatively rare tree could play a role in future cancer therapies. That’s a powerful idea. What really stands out in this work is not (just) in the findings themselves, but how they open the door to what comes next: breeding strategies, conservation actions, and practical applications. Such research shouldn’t exist in isolation; it should create momentum.
Prof. Filippos A. Aravanopoulos
Aristotle University of Thessaloniki
Read the Original
This page is a summary of: Genetic, epigenetic and metabolite variation in peripheral European Yew (Taxus baccata L.) populations at an unexplored part of the species natural distribution, PLOS One, March 2026, PLOS,
DOI: 10.1371/journal.pone.0324582.
You can read the full text:
Contributors
The following have contributed to this page
